Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Durvalumab Anlotinib Carboplatin Nab-paclitaxel
Locations
1
China
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
Start Date
February 8, 2021
Primary Completion Date
December 30, 2023
Completion Date
December 30, 2025
Last Updated
February 21, 2021
NCT06066138
NCT07485114
NCT05098132
NCT06284317
NCT06731413
NCT06687369
Lead Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions